Jahi Chikwendiu/The Washington Post via Getty Images
Major pharmaceutical companies like Eli Lilly are exploring how psychedelics might be used to treat mental health disorders like PTSD or treatment-resistant depression.
Medical marijuana is moving from Schedule I status, reserved for the most dangerous drugs like heroin and LSD, to Schedule III, like testosterone and steroids, which are less strictly regulated.